These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 24691061)

  • 1. A 6-year retrospective study of adverse drug reactions due to drug-drug interactions between nervous system drugs.
    Shi QP; He XD; Yu ML; Zhu JX; Liu Y; Ding F; Sang R; Jiang XD; Zhang SQ
    Int J Clin Pharmacol Ther; 2014 May; 52(5):392-401. PubMed ID: 24691061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy.
    Leone R; Magro L; Moretti U; Cutroneo P; Moschini M; Motola D; Tuccori M; Conforti A
    Drug Saf; 2010 Aug; 33(8):667-75. PubMed ID: 20635825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of adverse drug reactions in geriatric inpatients using a computerised drug database.
    Egger T; Dormann H; Ahne G; Runge U; Neubert A; Criegee-Rieck M; Gassmann KG; Brune K
    Drugs Aging; 2003; 20(10):769-76. PubMed ID: 12875612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of drug-drug interactions in hospitalized dermatology patients.
    Ganeva M; Gancheva T; Troeva J; Kiriyak N; Hristakieva E
    Adv Clin Exp Med; 2013; 22(4):555-63. PubMed ID: 23986216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Data-driven prediction of adverse drug reactions induced by drug-drug interactions.
    Liu R; AbdulHameed MDM; Kumar K; Yu X; Wallqvist A; Reifman J
    BMC Pharmacol Toxicol; 2017 Jun; 18(1):44. PubMed ID: 28595649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of adverse drug reactions using hospital databases-a nationwide study in Portugal.
    Miguel A; Bernardo Marques ; Freitas A; Lopes F; Azevedo L; Pereira AC
    Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):907-13. PubMed ID: 23761351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying and Characterizing Serious Adverse Drug Reactions Associated With Drug-Drug Interactions in a Spontaneous Reporting Database.
    Magro L; Arzenton E; Leone R; Stano MG; Vezzaro M; Rudolph A; Castagna I; Moretti U
    Front Pharmacol; 2020; 11():622862. PubMed ID: 33536925
    [No Abstract]   [Full Text] [Related]  

  • 8. [Analysis of adverse reactions and pharmacovigilance research to parenterally administered shuxuening].
    Yang W; Xiang YY; Xie YM; Shen H
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3013-8. PubMed ID: 24471322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug interactions between antihypertensive drugs and non-steroidal anti-inflammatory agents: a descriptive study using the French Pharmacovigilance database.
    Fournier JP; Sommet A; Durrieu G; Poutrain JC; Lapeyre-Mestre M; Montastruc JL;
    Fundam Clin Pharmacol; 2014 Apr; 28(2):230-5. PubMed ID: 23190210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions.
    Magro L; Moretti U; Leone R
    Expert Opin Drug Saf; 2012 Jan; 11(1):83-94. PubMed ID: 22022824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
    Toivo TM; Mikkola JA; Laine K; Airaksinen M
    Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug reactions caused by drug-drug interactions in cardiovascular disease patients: introduction of a simple prediction tool using electronic screening database items.
    Kovačević M; Vezmar Kovačević S; Radovanović S; Stevanović P; Miljković B
    Curr Med Res Opin; 2019 Nov; 35(11):1873-1883. PubMed ID: 31328967
    [No Abstract]   [Full Text] [Related]  

  • 13. Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis.
    Dechanont S; Maphanta S; Butthum B; Kongkaew C
    Pharmacoepidemiol Drug Saf; 2014 May; 23(5):489-97. PubMed ID: 24616171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacovigilance of parenterally administered salvianolate based on analysis of spontaneous reporting system data].
    Lu PF; Xiang YY; Xie YM; Chang YP; Wang ZG
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3003-7. PubMed ID: 24471320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacoepidemiological characterization of drug-induced adverse reaction clusters towards understanding of their mechanisms.
    Mizutani S; Noro Y; Kotera M; Goto S
    Comput Biol Chem; 2014 Jun; 50():50-9. PubMed ID: 24534381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care.
    Ramos GV; Guaraldo L; Japiassú AM; Bozza FA
    J Clin Pharm Ther; 2015 Feb; 40(1):63-7. PubMed ID: 25329640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding adverse drug reactions in older adults through drug-drug interactions.
    Marengoni A; Pasina L; Concoreggi C; Martini G; Brognoli F; Nobili A; Onder G; Bettoni D
    Eur J Intern Med; 2014 Nov; 25(9):843-6. PubMed ID: 25312593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seizure risk associated with neuroactive drugs: data from the WHO adverse drug reactions database.
    Kumlien E; Lundberg PO
    Seizure; 2010 Mar; 19(2):69-73. PubMed ID: 20036167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How many potential drug-drug interactions cause adverse drug reactions in hospitalized patients?
    Bucşa C; Farcaş A; Cazacu I; Leucuta D; Achimas-Cadariu A; Mogosan C; Bojita M
    Eur J Intern Med; 2013 Jan; 24(1):27-33. PubMed ID: 23041466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of monitoring adverse drug reactions in elderly patients: the results of a long-term pharmacovigilance programme.
    Carnovale C; Gentili M; Fortino I; Merlino L; Clementi E; Radice S; ViGer Group
    Expert Opin Drug Saf; 2016; 15(2):131-9. PubMed ID: 26882049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.